azfar zaman
azfar zaman
Freeman Hospital and Newcastle University, Newcastle upon Tyne, UK
Verified email at
Cited by
Cited by
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non …
T Mäkikallio, NR Holm, M Lindsay, MS Spence, A Erglis, IBA Menown, ...
The Lancet 388 (10061), 2743-2752, 2016
Preeclampsia and future cardiovascular health: a systematic review and meta-analysis
P Wu, R Haththotuwa, CS Kwok, A Babu, RA Kotronias, C Rushton, ...
Circulation: Cardiovascular Quality and Outcomes 10 (2), e003497, 2017
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease …
PS Douglas, G Pontone, MA Hlatky, MR Patel, BL Norgaard, RA Byrne, ...
European heart journal 36 (47), 3359-3367, 2015
The role of plaque rupture and thrombosis in coronary artery disease
AG Zaman, G Helft, SG Worthley, JJ Badimon
Atherosclerosis 149 (2), 251-266, 2000
Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification
AG Zaman, RA Archbold, G Helft, EA Paul, NP Curzen, PG Mills
Circulation 101 (12), 1403-1408, 2000
Thyroid hormones and cardiovascular function and diseases
S Razvi, A Jabbar, A Pingitore, S Danzi, B Biondi, I Klein, R Peeters, ...
Journal of the American College of Cardiology 71 (16), 1781-1796, 2018
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non …
NR Holm, T Mäkikallio, MM Lindsay, MS Spence, A Erglis, IBA Menown, ...
The Lancet 395 (10219), 191-199, 2020
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
J Escaned, C Collet, N Ryan, G Luigi De Maria, S Walsh, M Sabate, ...
European heart journal 38 (42), 3124-3134, 2017
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure
MT Kearney, KAA Fox, AJ Lee, RJ Prescott, AM Shah, PD Batin, W Baig, ...
Journal of the American College of Cardiology 40 (10), 1801-1808, 2002
Radial artery anomaly and its influence on transradial coronary procedural outcome
TS Lo, J Nolan, E Fountzopoulos, M Behan, R Butler, SL Hetherington, ...
Heart 95 (5), 410-415, 2009
Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain? The RIPCORD study
N Curzen, O Rana, Z Nicholas, P Golledge, A Zaman, K Oldroyd, ...
Circulation: Cardiovascular Interventions 7 (2), 248-255, 2014
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
Polymer-based or polymer-free stents in patients at high bleeding risk
S Windecker, A Latib, E Kedhi, AJ Kirtane, DE Kandzari, R Mehran, ...
New England Journal of Medicine 382 (13), 1208-1218, 2020
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control
JI Osende, JJ Badimon, V Fuster, P Herson, P Rabito, R Vidhun, A Zaman, ...
Journal of the American College of Cardiology 38 (5), 1307-1312, 2001
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis
SG Worthley, G Helft, V Fuster, AG Zaman, ZA Fayad, JT Fallon, ...
Circulation 101 (6), 586-589, 2000
Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras
RM Cubbon, CP Gale, LC Kearney, CB Schechter, WP Brooksby, J Nolan, ...
Circulation: Heart Failure 4 (4), 396-403, 2011
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents
A Natarajan, AG Zaman, SM Marshall
Diabetes and Vascular Disease Research 5 (2), 138-144, 2008
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
AG Zaman, MT Kearney, C Schecter, SG Worthley, J Nolan
American Heart Journal 147 (5), 823-827, 2004
The system can't perform the operation now. Try again later.
Articles 1–20